Attached files
| file | filename |
|---|---|
| 8-K - 8-K - Inotiv, Inc. | v334864_8k.htm |
| EX-99.1 - EXHIBIT 99.1 - Inotiv, Inc. | v334864_ex99-1.htm |
February12, 2013
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, N. E.
Washington, D.C. 20549
Ladies and Gentlemen:
We have read the comments made regarding us in Item 4.01 (a) of Form 8-K of Bioanalytical Systems, Inc. dated February 12, 2013 and are in agreement with those statements.
Crowe Horwath LLP
Fort Wayne, Indiana
| cc: | Mr. Larry Boulet |
| Audit Committee Chairman | |
| Bioanalytical Systems, Inc. |